Aberrant Immunological Synapses Driven by Leukemic Antigen-Presenting Cells.

about

Aberrant Immunological Synapses Driven by Leukemic Antigen-Presenting Cells.

Item

http://www.wikidata.org/entity/Q52897863

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Aberrant Immunological Synapses Driven by Leukemic Antigen-Presenting Cells.

@en

Aberrant Immunological Synapses Driven by Leukemic Antigen-Presenting Cells.

@nl

type

Item

label

Aberrant Immunological Synapses Driven by Leukemic Antigen-Presenting Cells.

@en

Aberrant Immunological Synapses Driven by Leukemic Antigen-Presenting Cells.

@nl

prefLabel

Aberrant Immunological Synapses Driven by Leukemic Antigen-Presenting Cells.

@en

Aberrant Immunological Synapses Driven by Leukemic Antigen-Presenting Cells.

@nl

P1476

Aberrant Immunological Synapses Driven by Leukemic Antigen-Presenting Cells.

@en

P2093

John G Gribben

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic lymphocytic leukemia cells induce defective LFA-1-directed T-cell motility by altering Rho GTPase signaling that is reversible with lenalidomide.

Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells.

PD-L1 checkpoint blockade prevents immune dysfunction and leukemia development in a mouse model of chronic lymphocytic leukemia

Mechanisms of PD-L1/PD-1-mediated CD8 T-cell dysfunction in the context of aging-related immune defects in the Eµ-TCL1 CLL mouse model.

Multiple inhibitory ligands induce impaired T-cell immunologic synapse function in chronic lymphocytic leukemia that can be blocked with lenalidomide: establishing a reversible immune evasion mechanism in human cancer.

Peripheral blood T cells in acute myeloid leukemia (AML) patients at diagnosis have abnormal phenotype and genotype and form defective immune synapses with AML blasts.

Immunotherapeutic strategies including transplantation: eradication of disease.

Cord blood natural killer cells exhibit impaired lytic immunological synapse formation that is reversed with IL-2 exvivo expansion.

Long-term repair of T-cell synapse activity in a phase II trial of chemoimmunotherapy followed by lenalidomide consolidation in previously untreated chronic lymphocytic leukemia (CLL).

P304

533-544

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/978-1-4939-6881-7_33

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

1584

http://www.w3.org/2001/XMLSchema#string

P50

Fabienne Lucas

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28255724

http://www.w3.org/2001/XMLSchema#string

P921

immunology

leukemia